Heterocycles with Nitrogen (N)

<p>4-Hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine is a pyrimidine compound that is a competitive inhibitor of xanthine oxidase (XO) with an IC50 of 0.5 μM. It binds reversibly to the XO enzyme and reverses the effect of the enzyme, thereby inhibiting the production of uric acid. 4-Hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine does not bind to any other enzymes in the body or affect serum protein levels, which makes it an ideal drug for patients with gout who are at risk for developing renal failure. The drug has been shown to be effective in animal models and is currently undergoing clinical trials in humans.</p>

<p>Piperazine-2-carboxylic acid dihydrochloride (PZC) is an aminopyrimidine antibiotic that binds to the amine groups of plasma proteins and hydroxyapatite. It has been shown to have a specific interaction with Gram-negative bacteria, such as Escherichia coli and Salmonella typhimurium, as well as cancer cells. PZC can be used as a modifier in the treatment of staphylococcal infections and has been shown to inhibit protein synthesis in mammalian cells. PZC interacts with histidine residues on the surface of bacterial cells and inhibits their growth by binding to sites on DNA called triplexes. This drug also specifically binds to primary amines and reacts with other molecules containing amines such as polyamines, amides, or thiols.</p>

<p>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine is a drug that inhibits serotonin reuptake. It has been used to treat a number of neurological disorders including depression and Parkinson's disease. This drug is a nonselective inhibitor of serotonin uptake and also inhibits the reuptake of norepinephrine. 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine has been shown to enhance cardiac contractility without altering heart rate or rhythm in anesthetized dogs with experimental coronary artery occlusion. The drug also reversibly inhibits epileptic seizures in rats when administered intravenously at a dose of 1 mg/kg. 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidine has been shown to have insulin resistance effects in mice with diabetes mellitus and may be useful as a pharmaceutical</p>

<p>3-Pyridineboronic acid is an antimicrobial agent that is used to treat bacterial and fungal infections. 3-Pyridineboronic acid is a prodrug that is metabolized to its active form, pyridinium boronate. This drug has been shown to be effective in the treatment of hypoxic tumors in mice, which are resistant to other anticancer drugs. 3-Pyridineboronic acid also has acidic properties and can be used as an antiseptic for the treatment of skin and eye infections. It can also be used as a hydrogen bonding partner when combined with halides, such as chloride or bromide ions. The drug binds to human serum proteins and forms an acidic complex that prevents bacterial growth by inhibiting protein synthesis. 3-Pyridineboronic acid also inhibits prostate cancer cells by competitively inhibiting the enzyme 4-pyridinylboronic acid reductase (4PBAR).</p>

<p>4-Imidazole methyl carboxylate is a drug that inhibits the activity of dehydrogenases and other enzymes. It has been shown to be an inhibitor of the enzyme catalase in vitro and in vivo, which may be due to its ability to bind bidentately with the active site. 4-Imidazole methyl carboxylate is effective when administered orally, and it has been shown to improve symptoms of neurodegenerative diseases such as Alzheimer's disease. This drug also has a trifunctional chemical structure that contains a macrocyclic ring system with an imidazole group and a carboxylic acid group. The redox potential of this molecule makes it suitable for use as an antioxidant.</p>

<p>Please enquire for more information about 1-Boc-2-methyl (2R,3S)-3-hydroxypyrrolidine-2-carboxylate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about [4,4'-Di-t-butyl-2,2'-bipyridine][bis[5-(t-butyl)-2-[4-(t-butyl)-2-pyridinyl-kN]phenyl-kC]iridium(III) hexafluorophosphate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Piperazinoacetic acid anilide dihydrochloride is a high quality, reagent compound which can be used as a useful intermediate or a speciality chemical. Piperazinoacetic acid anilide dihydrochloride is a complex compound that has been shown to have a number of useful properties, such as being an effective building block for the synthesis of other compounds. It can also be used as a reaction component in the preparation of fine chemicals and research chemicals. This product is also versatile, allowing it to be built into different scaffolds to create new compounds.</p>

<p>4,6-Dichloro-5-nitropyrimidine is an intermediate in the synthesis of Tenofovir, a nucleophilic drug that inhibits HIV. It is produced by the reaction of chloride with amines and nitro compounds in the presence of ammonium chloride. 4,6-Dichloro-5-nitropyrimidine has been shown to have anticancer activity against human lymphocytes and other cancer cells. It can also be used for the treatment of AIDS. The biological properties of this compound are dose dependent and are dependent on the size of chlorine atoms attached to nitrogen atoms.</p>

<p>Please enquire for more information about 2-chloro-3-fluoropyridin-4-amine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>3-Piperidin-1-ylpropanoic acid is a hydroxylated compound that belongs to the group of aromatic hydrocarbons. It has been shown to inhibit the activity of enzymes such as model studies and test compounds, which are used in biological samples. 3-Piperidin-1-ylpropanoic acid is not active against mouse tumor cells and does not show any locomotor activity. The terminal half life of this drug has been determined in urine samples from mice at 20 hours.</p>

<p>Please enquire for more information about Deschloro amlodipine maleate including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Pyrimidine nucleobase; component of nucleic acids</p>

<p>Please enquire for more information about 3-Bromo-6-methylpicolinic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>4-(tert-Butyldimethylsilyloxymethyl)pyridine is a reagent that is used to prepare stoichiometric quantities of triethyloxonium ions in the presence of catalytic amounts of palladium. 4-(tert-Butyldimethylsilyloxymethyl)pyridine is also used as an anticancer agent, which may be due to its ability to inhibit cell proliferation and induce apoptosis. This compound has been shown to prevent the growth of micellar structures and reduce the rate of ester hydrolysis. It also has the ability to convert into two enantiomers, one with a hydroxyl group on the methylene carbon at position 4 and another with an alcohol group on this same carbon.</p>

<p>2-Chloropyridine-4-boronic acid is a nicotinic acetylcholine receptor antagonist that has been shown to be effective against trypanosomiasis. It blocks the binding of acetylcholine to its receptor, which prevents the propagation of an action potential in the postsynaptic cell. 2-Chloropyridine-4-boronic acid inhibits the enzymes cyclooxygenase and prostaglandin synthase, which are involved in inflammation. 2-Chloropyridine-4-boronic acid is potent and selective for nicotinic acetylcholine receptors, but it also binds to other sites on the enzyme. The molecular modeling studies have shown that this compound has a pharmacophore that can be used as a guide for drug design.</p>

<p>Intermediate in the synthesis of tedizolid</p>

<p>(S)-1-Boc-3-methylpiperazine is a hydrophobic compound that is structurally modified from the tetracyclic family of drugs. It has been shown to inhibit tumor cell growth by binding to the oncogene, KRASG12C, and downregulating its expression. (S)-1-Boc-3-methylpiperazine also inhibits cancer cell growth through the inhibition of the PI3K/AKT signaling pathway. The pharmacological effects of (S)-1-Boc-3-methylpiperazine are dependent on its ability to bind with high affinity to KRASG12C and inhibit its activity.</p>

<p>3-Iodo-1H-pyrrolo[2,3-b]pyridine (3IOP) is a molecule that has been shown to be cytotoxic against human ovarian carcinoma cells. It induces significant cytotoxicity in cancer cell lines and inhibits the proliferation of lung fibroblasts. 3IOP has been shown to activate cellular signaling pathways and cause multinuclear DNA damage.</p>

<p>Please enquire for more information about 3-(cis-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>